Cargando…

Hypoxia and chronic kidney disease

Hypoxia is an inherent pathophysiological characteristic of chronic kidney disease (CKD), which is closely associated with the development of renal inflammation and fibrosis, as well as CKD-related complications such as anaemia, cardiovascular events, and sarcopenia. This review outlined the charact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Bin, Li, Zuo-Lin, Zhang, Yi-Lin, Wen, Yi, Gao, Yue-Ming, Liu, Bi-Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921539/ https://www.ncbi.nlm.nih.gov/pubmed/35290825 http://dx.doi.org/10.1016/j.ebiom.2022.103942

Ejemplares similares

Activation of HIF-1α C-terminal transactivation domain protects against hypoxia-induced kidney injury through hexokinase 2-mediated mitophagy
por: Li, Zuo-Lin, et al.
Publicado: (2023)

Development and External Validation of a Nomogram and a Risk Table for Prediction of Type 2 Diabetic Kidney Disease Progression Based on a Retrospective Cohort Study in China
por: Gao, Yue-Ming, et al.
Publicado: (2022)

Hypoxia, HIF, and Associated Signaling Networks in Chronic Kidney Disease
por: Liu, Jing, et al.
Publicado: (2017)

Urinary Biomarkers for Chronic Kidney Disease with a Focus on Gene Transcript
por: Lyu, Lin-Li, et al.
Publicado: (2017)

Acute Kidney Injury in the 2019 Novel Coronavirus Disease
por: Qian, Jing-Yi, et al.
Publicado: (2020)

Hypoxia and fibrosis in chronic kidney disease: crossing at pericytes
por: Kawakami, Takahisa, et al.
Publicado: (2014)

Therapeutic application of extracellular vesicles in kidney disease: promises and challenges
por: Lv, Lin‐Li, et al.
Publicado: (2017)

Pathogenesis of Acute Kidney Injury in Coronavirus Disease 2019
por: Qian, Jing-Yi, et al.
Publicado: (2021)

Flavonoids in Treatment of Chronic Kidney Disease
por: Cao, Yi-Ling, et al.
Publicado: (2022)

Role of Calcimimetics in Treating Bone and Mineral Disorders Related to Chronic Kidney Disease
por: Hou, Yi-Chou, et al.
Publicado: (2022)

Indoxyl Sulfate, a Tubular Toxin, Contributes to the Development of Chronic Kidney Disease
por: Cheng, Tong-Hong, et al.
Publicado: (2020)

Effects of hypoxia on bone metabolism and anemia in patients with chronic kidney disease
por: Kan, Chao, et al.
Publicado: (2021)

The Efficacy of COVID-19 Vaccines in Chronic Kidney Disease and Kidney Transplantation Patients: A Narrative Review
por: Hou, Yi-Chou, et al.
Publicado: (2021)

Mechanisms of ferroptosis in chronic kidney disease
por: Zhuo, Wen-Qing, et al.
Publicado: (2022)

Role of antidiabetic agents in type 2 diabetes patients with chronic kidney disease
por: Lin, Wei-Ren, et al.
Publicado: (2023)

Hypoxia-Inducible Factor and Its Role in the Management of Anemia in Chronic Kidney Disease
por: Kaplan, Joshua M., et al.
Publicado: (2018)

Hypoxia and Hypoxia-Inducible Factors in Kidney Injury and Repair
por: Shu, Shaoqun, et al.
Publicado: (2019)

Influence of Resveratrol on the Cardiovascular Health Effects of Chronic Kidney Disease
por: Song, Jenn-Yeu, et al.
Publicado: (2020)

Indoxyl-Sulfate-Induced Redox Imbalance in Chronic Kidney Disease
por: Lu, Chien-Lin, et al.
Publicado: (2021)

Role of crosstalk between endothelial cells and smooth muscle cells in vascular calcification in chronic kidney disease
por: Zhang, Yu‐Xia, et al.
Publicado: (2021)

Autophagy in Chronic Kidney Diseases
por: Lin, Tien-An, et al.
Publicado: (2019)

Renal expression of hypoxia inducible factor-1α in patients with chronic kidney disease: a clinicopathologic study from nephrectomized kidneys
por: Tung-Wei, Hung, et al.
Publicado: (2013)

Hypoxia Induced Factor in Chronic Kidney Disease: Friend or Foe?
por: Li, Weiying, et al.
Publicado: (2018)

Chronic Kidney Disease: Strategies to Retard Progression
por: Yan, Ming-Tso, et al.
Publicado: (2021)

New insight into the role of extracellular vesicles in kidney disease
por: Lv, Lin‐Li, et al.
Publicado: (2018)

Evolution of hypoxia and hypoxia-inducible factor asparaginyl hydroxylase regulation in chronic kidney disease
por: Faivre, Anna, et al.
Publicado: (2023)

Cardiorenal protection of SGLT2 inhibitors—Perspectives from metabolic reprogramming
por: Gao, Yue-Ming, et al.
Publicado: (2022)

Harmonizing Formula Prescription Patterns in Patients With Chronic Kidney Disease: A Population-Based Cross-Sectional Study
por: Lin, Hung-Lung, et al.
Publicado: (2021)

Sestrin2 in hypoxia and hypoxia-related diseases
por: Che, Xiaojing, et al.
Publicado: (2021)

Metabolic signatures of immune cells in chronic kidney disease
por: Li, Jie, et al.
Publicado: (2022)

The role of klotho in chronic kidney disease
por: Zou, Di, et al.
Publicado: (2018)

A Novel Creatinine-Based Equation to Estimate Glomerular Filtration Rate in Chinese Population With Chronic Kidney Disease: Implications for DOACs Dosing in Atrial Fibrillation Patients
por: Zhou, Ling-Yun, et al.
Publicado: (2021)

Macrophage Heterogeneity in Kidney Injury and Fibrosis
por: Wen, Yi, et al.
Publicado: (2021)

Circulating Endothelial Cells and Chronic Kidney Disease
por: Zhang, Kunying, et al.
Publicado: (2014)

Impact of Weaning from Acute Dialytic Therapy on Outcomes of Chronic Kidney Disease following Urgent-Start Dialysis
por: Chen, Yung-Ming, et al.
Publicado: (2015)

Association of physical activity with cardiovascular and renal outcomes and quality of life in chronic kidney disease
por: Tsai, Yi-Chun, et al.
Publicado: (2017)

Role of Vitamin D in Cognitive Function in Chronic Kidney Disease
por: Cheng, Zhen, et al.
Publicado: (2016)

Complications after radiofrequency ablation of hyperparathyroidism secondary to chronic kidney disease
por: Lin, Li-Ping, et al.
Publicado: (2023)

MMP-2 and 9 in Chronic Kidney Disease
por: Cheng, Zhengyuan, et al.
Publicado: (2017)

Hypoxia in Diabetic Kidneys
por: Takiyama, Yumi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_e0nmve2rfr08bkcob53p815b65